Dr Divyanshu Dua

Dr Divyanshu 'Divy' Dua is an experienced consultant medical oncologist based in Richmond, Melbourne, Victoria, Australia. He specialises in the treatment of cancerous conditions and is affiliated with the National Capital Private Hospital. Dr Dua is a male healthcare professional fluent in English, Hindi, and Punjabi.

With a primary focus on malignant melanoma, breast cancer, genitourinary cancer, sarcoma, neuroendocrine cancer, and tumors of the central nervous system, Dr Dua has dedicated his career to the management and treatment of these conditions.

After completing his training in Internal Medicine and Medical Oncology in Australia, Dr Dua obtained his FRACP certification from the Royal Australasian College of Physicians. He then pursued a clinical fellowship in drug development, early-phase trials, and thoracic malignancies at Guy's Hospital in London and the Sarah Cannon Research Institute in the UK.

Dr Dua is widely recognized for his exceptional skills in managing thoracic malignancies such as mesothelioma, lung cancer, and thymoma. He also specialises in the diagnosis and treatment of genitourinary malignancies, including prostate cancer, CNS tumors, breast cancer, and malignant melanoma.

In addition to his clinical practice, Dr Dua has been actively involved in teaching and research. He has authored numerous articles in peer-reviewed international journals and is affiliated with the Australian National University in Canberra. Previously, he has been associated with institutions such as Monash Rural School of Medicine, University of Adelaide, Flinders University, and King's College London.

Dr Dua has a particular interest in geriatric oncology services and has been running a multidisciplinary clinic in Canberra for the past four years. Furthermore, he actively participates in the training of the Physician training program, further contributing to the medical community.

In summary, Dr Divyanshu Dua is a highly competent and committed medical oncologist, specialising in thoracic and genitourinary malignancies. With extensive experience, exceptional skills, and a dedication to research and teaching, he is a valuable asset to the healthcare industry.